These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Health: Make precision medicine work for cancer care. Rubin MA Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189 [No Abstract] [Full Text] [Related]
6. Delivering on the promise of precision cancer medicine. Berger MF; Van Allen EM Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852 [No Abstract] [Full Text] [Related]
7. Clinical medicine. Biomarker tests need closer scrutiny, IOM concludes. Kaiser J Science; 2012 Mar; 335(6076):1554. PubMed ID: 22461579 [No Abstract] [Full Text] [Related]
8. Cancer research needs a better map. Boehm JS; Garnett MJ; Adams DJ; Francies HE; Golub TR; Hahn WC; Iorio F; McFarland JM; Parts L; Vazquez F Nature; 2021 Jan; 589(7843):514-516. PubMed ID: 33500573 [No Abstract] [Full Text] [Related]
9. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. Farwell MD; Clark AS; Mankoff DA JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243 [No Abstract] [Full Text] [Related]
10. A Precision Medicine Approach to Clinical Trials. Rubin R JAMA; 2016 Nov; 316(19):1953-1955. PubMed ID: 27760248 [No Abstract] [Full Text] [Related]
11. Group mentality: Determining if targeted treatments really work for cancer. Chakradhar S Nat Med; 2016 Mar; 22(3):222-4. PubMed ID: 26937611 [No Abstract] [Full Text] [Related]
12. DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance? Voest EE; Bernards R Cancer Discov; 2016 Feb; 6(2):130-2. PubMed ID: 26851184 [TBL] [Abstract][Full Text] [Related]
13. What Happens When Underperforming Big Ideas in Research Become Entrenched? Joyner MJ; Paneth N; Ioannidis JP JAMA; 2016 Oct; 316(13):1355-1356. PubMed ID: 27467098 [No Abstract] [Full Text] [Related]
14. Pitfalls of Personalizing Cancer Treatment. Perez K Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382 [No Abstract] [Full Text] [Related]
15. Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back. Chau NG; Lorch JH Oncologist; 2015 Jul; 20(7):699-701. PubMed ID: 26040619 [TBL] [Abstract][Full Text] [Related]
16. Cancer: The Ras renaissance. Ledford H Nature; 2015 Apr; 520(7547):278-80. PubMed ID: 25877186 [No Abstract] [Full Text] [Related]
17. Perspective: The precision-oncology illusion. Prasad V Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743 [No Abstract] [Full Text] [Related]
18. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
19. Using Somatic Mutations to Guide Treatment Decisions: Context Matters. Horlings HM; Shah SP; Huntsman DG JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166 [No Abstract] [Full Text] [Related]
20. Precision cancer medicine: where to target? Yu Q; Ding J Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154 [No Abstract] [Full Text] [Related] [Next] [New Search]